PMID- 20722564 OWN - NLM STAT- MEDLINE DCOM- 20110201 LR - 20161125 IS - 1525-6049 (Electronic) IS - 0886-022X (Linking) VI - 32 IP - 8 DP - 2010 TI - Protective effect of trapidil and l-arginine against renal and hepatic toxicity induced by cyclosporine in rats. PG - 959-68 LID - 10.3109/0886022X.2010.501933 [doi] AB - RATIONALE: Cyclosporine A (CsA) leads to renal and liver injury, production of free radicals and nitric oxide (NO) deficiency. This study investigates the possible protective effects of trapidil and L-arginine against CsA-induced tissue injury. OBJECTIVES: Forty adult male Wistar rats (180 +/- 20 g) were divided into five groups, eight animals in each. The first group served as control, second group served as CsA group, third group served as CsA + trapidil group, fourth group served as CsA + L-arginine group, and fifth group served as CsA + trapidil + L-arginine group. Kidney and liver functions, inflammatory mediators, cytokines, oxidant and antioxidant parameters as well as histopathological studies of renal and liver tissue were assessed in all groups. MAIN FINDINGS: CsA induced renal and hepatic dysfunction, which was confirmed by laboratory and histopathological examination. Administration of trapidil diminished the renal and liver injury and significantly attenuated the levels of serum creatinine, urea, aspartate aminotransferase (AST), alanine aminotransferase (ALT), interleukin-1beta (IL-1beta), tumor necrosis factor alpha (TNF-alpha), monocyte chemoattractant protein-1 (MCP-1), and oxidative stress, while it significantly elevated the level of serum nitric oxide and the activity of antioxidative stress. L-Arginine gave the same trend as trapidil, but trapidil effect was more pronounced. Coadministration of trapidil + L-arginine significantly ameliorated the toxic effect of CsA, but did not differ significantly from the effect of trapidil alone. CONCLUSIONS: Treatment with trapidil or L-arginine diminished the renal and hepatic CsA-induced toxicity. However, the effect of trapidil was more pronounced. Therefore, treatment with trapidil alone may be the most economic and effective as a potential therapeutic agent in CsA injury. FAU - Salem, Neveen A AU - Salem NA AD - Medical Division, National Research Centre, Cairo, Egypt. FAU - Salem, Emad A AU - Salem EA FAU - Maarouf, Aref M AU - Maarouf AM FAU - Kamel, Mostafa AU - Kamel M FAU - Elgalaly, Hazem AU - Elgalaly H FAU - Radwan, Mohamed AU - Radwan M FAU - El-Dayem, Walid A Abd AU - El-Dayem WA FAU - Eladl, Mahmoud AU - Eladl M LA - eng PT - Journal Article PL - England TA - Ren Fail JT - Renal failure JID - 8701128 RN - 0 (Immunosuppressive Agents) RN - 0 (Vasodilator Agents) RN - 31C4KY9ESH (Nitric Oxide) RN - 83HN0GTJ6D (Cyclosporine) RN - 94ZLA3W45F (Arginine) RN - EYG5Y6355E (Trapidil) SB - IM MH - Animals MH - Arginine/*therapeutic use MH - Chemical and Drug Induced Liver Injury/etiology/pathology/*prevention & control MH - Cyclosporine/*adverse effects MH - Immunosuppressive Agents/adverse effects MH - Kidney Diseases/chemically induced/pathology/*prevention & control MH - Male MH - Nitric Oxide/physiology MH - Oxidative Stress/physiology MH - Rats MH - Rats, Wistar MH - Trapidil/*therapeutic use MH - Vasodilator Agents/*therapeutic use EDAT- 2010/08/21 06:00 MHDA- 2011/02/02 06:00 CRDT- 2010/08/21 06:00 PHST- 2010/08/21 06:00 [entrez] PHST- 2010/08/21 06:00 [pubmed] PHST- 2011/02/02 06:00 [medline] AID - 10.3109/0886022X.2010.501933 [doi] PST - ppublish SO - Ren Fail. 2010;32(8):959-68. doi: 10.3109/0886022X.2010.501933.